Michael H. Weisman, MD, is Director of the Division of Rheumatology at Cedar-Sinai Medical Center, Professor of Medicine at the David Geffen School of Medicine at University of California, Los Angeles, and Professor Emeritus of Medicine at University of California, San Diego School of Medicine.

• Chapter 1: History of Rheumatoid Arthritis ; Chapter 2: Definition and Classification ; Chapter 3: Epidemiology ; Chapter 4: Pathogenesis ; Chapter 5: Clinical Signs and Symptoms ; Chapter 6: Comorbidities and RA ; Chapter 7: Pregnancy ; Chapter 8: Outcome Measurement ; Chapter 9: Laboratory and Imaging Assessments ; Chapter 10: Differential Diagnosis ; Chapter 11: Medications Used to Manage RA ; Chapter 12: Economic Impact and Disability Issues ; Chapter 13: Prognosis ; Glossary ; Appendix: Rheumatoid Arthritis Resource Materials

Michael H. Weisman, MD, is Director of the Division of Rheumatology at Cedar-Sinai Medical Center, Professor of Medicine at the David Geffen School of Medicine at University of California, Los Angeles, and Professor Emeritus of Medicine at University of California, San Diego School of Medicine.

• Chapter 1: History of Rheumatoid Arthritis ; Chapter 2: Definition and Classification ; Chapter 3: Epidemiology ; Chapter 4: Pathogenesis ; Chapter 5: Clinical Signs and Symptoms ; Chapter 6: Comorbidities and RA ; Chapter 7: Pregnancy ; Chapter 8: Outcome Measurement ; Chapter 9: Laboratory and Imaging Assessments ; Chapter 10: Differential Diagnosis ; Chapter 11: Medications Used to Manage RA ; Chapter 12: Economic Impact and Disability Issues ; Chapter 13: Prognosis ; Glossary ; Appendix: Rheumatoid Arthritis Resource Materials

Michael H. Weisman, MD, is Director of the Division of Rheumatology at Cedar-Sinai Medical Center, Professor of Medicine at the David Geffen School of Medicine at University of California, Los Angeles, and Professor Emeritus of Medicine at University of California, San Diego School of Medicine.

• Chapter 1: History of Rheumatoid Arthritis ; Chapter 2: Definition and Classification ; Chapter 3: Epidemiology ; Chapter 4: Pathogenesis ; Chapter 5: Clinical Signs and Symptoms ; Chapter 6: Comorbidities and RA ; Chapter 7: Pregnancy ; Chapter 8: Outcome Measurement ; Chapter 9: Laboratory and Imaging Assessments ; Chapter 10: Differential Diagnosis ; Chapter 11: Medications Used to Manage RA ; Chapter 12: Economic Impact and Disability Issues ; Chapter 13: Prognosis ; Glossary ; Appendix: Rheumatoid Arthritis Resource Materials